ENST00000453168.5:n.129A>C
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The ENST00000453168.5(STT3B):n.129A>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 614,494 control chromosomes in the GnomAD database, including 12,250 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000453168.5 non_coding_transcript_exon
Scores
Clinical Significance
Conservation
Publications
- STT3B-congenital disorder of glycosylationInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: G2P, PanelApp Australia, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000453168.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.190 AC: 28814AN: 151704Hom.: 2880 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.199 AC: 92105AN: 462670Hom.: 9369 Cov.: 7 AF XY: 0.200 AC XY: 47312AN XY: 237118 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.190 AC: 28822AN: 151824Hom.: 2881 Cov.: 33 AF XY: 0.190 AC XY: 14080AN XY: 74200 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at